Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
From MaRDI portal
(Redirected from Publication:680423)
Recommendations
- The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data
- The optimal age of vaccination against dengue with an age-dependent biting rate with application to Brazil
- Country- and age-specific optimal allocation of dengue vaccines
- A two-age-classes dengue transmission model
- Vaccination models and optimal control strategies to dengue
Cites work
- A two-age-classes dengue transmission model
- Analysis of a dengue disease transmission model
- Backward bifurcations in dengue transmission dynamics
- Coexistence of different serotypes of dengue virus
- Dengue fever: Mathematical modelling and computer simulation
- Optimal ages of vaccination for measles
- The potential impact of vaccination on the dynamics of dengue infections
- Vaccinations in disease models with antibody-dependent enhancement
Cited in
(13)- Optimal vaccine allocation for the control of sexually transmitted infections
- Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission
- Cross immunity protection and antibody-dependent enhancement in a distributed delay dynamic model
- The optimal age of vaccination against dengue with an age-dependent biting rate with application to Brazil
- Estimation of the expected number of cases of microcephaly in Brazil as a result of zika
- Optimal control strategies for dengue transmission in Pakistan
- Modelling the effect of a novel autodissemination trap on the spread of dengue in Shah Alam and Malaysia
- Optimal dengue vaccination strategies of seropositive individuals
- Vaccination and vector control effect on dengue virus transmission dynamics: modelling and simulation
- An optimal control problem for dengue transmission model with \textit{Wolbachia} and vaccination
- The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data
- Country- and age-specific optimal allocation of dengue vaccines
- Disease persistence and serotype coexistence: an expected feature of human mobility
This page was built for publication: Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q680423)